Independence Bank of Kentucky’s Novavax NVAX Stock Holding History

Independence Bank of Kentucky’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-142	Closed	-$954	–	693
2025 Q4	$954	Hold	142	–	–	﹤0.01%	693
2025 Q3	$1.23K	Hold	142	–	–	﹤0.01%	613
2025 Q2	$895	Hold	142	–	–	﹤0.01%	608
2025 Q1	$910	Hold	142	–	–	﹤0.01%	605
2024 Q4	$1.14K	Hold	142	–	–	﹤0.01%	610
2024 Q3	$1.79K	Hold	142	–	–	﹤0.01%	569
2024 Q2	$1.8K	Hold	142	–	–	﹤0.01%	521
2024 Q1	$679	Hold	142	–	–	﹤0.01%	512
2023 Q4	$682	Hold	142	–	–	﹤0.01%	515
2023 Q3	$1.03K	Hold	142	–	–	﹤0.01%	478
2023 Q2	$1.05K	Hold	142	–	–	﹤0.01%	504
2023 Q1	$984	Hold	142	–	–	﹤0.01%	419
2022 Q4	$1K	Hold	142	–	–	﹤0.01%	433
2022 Q3	$3K	Hold	142	–	–	﹤0.01%	397
2022 Q2	$7K	Hold	142	–	–	﹤0.01%	364
2022 Q1	$10K	Hold	142	–	–	﹤0.01%	351
2021 Q4	$20K	Hold	142	–	–	0.01%	297
2021 Q3	$29K	Hold	142	–	–	0.01%	284
2021 Q2	$30K	Hold	142	–	–	0.01%	279
2021 Q1	$26K	Hold	142	–	–	0.01%	282
2020 Q4	$16K	Hold	142	–	–	0.01%	301
2020 Q3	$15K	Hold	142	–	–	0.01%	296
2020 Q2	$12K	Hold	142	–	–	0.01%	281
2020 Q1	$2K	Buy	+142	New	+$1.2K	﹤0.01%	332

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Independence Bank of Kentucky's NVAX Position: Q1 2026 in Review

Independence Bank of Kentucky sold out of Novavax (NVAX) in Q1 2026, closing a stake of 142 shares — an estimated $954 sold.

Independence Bank of Kentucky first reported a position in NVAX in Q1 2020 and held it in 24 quarters. The position peaked at $30K in Q2 2021. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

Independence Bank of Kentucky reported no remaining Novavax position as of Q1 2026 after selling out during the quarter.
Independence Bank of Kentucky sold 142 Novavax shares in Q1 2026, an estimated $954.
Independence Bank of Kentucky first reported a position in Novavax in Q1 2020 and held it in 24 quarters.
Independence Bank of Kentucky's Novavax position peaked at $30K in Q2 2021.
258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Independence Bank of Kentucky's 13F filing for Q1 2026, filed 30 Apr 2026.